| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.19B | 123.98B | 126.01B | 134.58B | 120.68B | 100.30B |
| Gross Profit | 47.10B | 46.55B | 45.99B | 48.99B | 45.71B | 36.58B |
| EBITDA | 11.47B | 11.63B | 12.94B | 16.44B | 16.20B | 9.48B |
| Net Income | 4.91B | 4.78B | 5.58B | 9.19B | 9.57B | 4.80B |
Balance Sheet | ||||||
| Total Assets | 112.99B | 113.96B | 108.72B | 109.03B | 91.71B | 78.84B |
| Cash, Cash Equivalents and Short-Term Investments | 11.72B | 12.30B | 12.98B | 12.88B | 8.16B | 9.60B |
| Total Debt | 28.71B | 30.08B | 26.23B | 28.17B | 21.02B | 21.80B |
| Total Liabilities | 53.08B | 52.69B | 54.23B | 61.55B | 54.23B | 51.26B |
| Stockholders Equity | 59.68B | 61.02B | 54.26B | 47.30B | 37.31B | 27.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.69B | 6.37B | -118.00M | 798.00M | 12.05B |
| Operating Cash Flow | 0.00 | 2.04B | 12.40B | 4.16B | 6.96B | 15.84B |
| Investing Cash Flow | 0.00 | -4.19B | -6.31B | -3.87B | -6.85B | -3.38B |
| Financing Cash Flow | 0.00 | 1.01B | -6.38B | 4.65B | -2.47B | -8.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥9.10B | 16.36 | ― | 3.96% | 7.77% | 247.26% | |
67 Neutral | ¥246.51B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
63 Neutral | ¥1.40T | 42.60 | 5.92% | 1.93% | 7.64% | 22.13% | |
62 Neutral | ¥275.63B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥26.69B | 14.57 | ― | 1.85% | 4.17% | -20.08% | |
49 Neutral | ¥47.23B | 11.29 | ― | 3.94% | 0.74% | 41.25% |